Arnaud Murat

6.1k total citations
28 papers, 3.1k citations indexed

About

Arnaud Murat is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Arnaud Murat has authored 28 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 13 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Oncology. Recurrent topics in Arnaud Murat's work include Neuroendocrine Tumor Research Advances (17 papers), Pituitary Gland Disorders and Treatments (7 papers) and Thyroid Cancer Diagnosis and Treatment (7 papers). Arnaud Murat is often cited by papers focused on Neuroendocrine Tumor Research Advances (17 papers), Pituitary Gland Disorders and Treatments (7 papers) and Thyroid Cancer Diagnosis and Treatment (7 papers). Arnaud Murat collaborates with scholars based in France, Belgium and Poland. Arnaud Murat's co-authors include Pierre Goudet, Alain Calender, Patricia Niccoli‐Sire, P Cougard, Brigitte Delemer, Albert Beckers, V. Rohmer, Guillaume Cadiot, C Proye and Bruno Vergès and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Arnaud Murat

28 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnaud Murat France 23 1.4k 1.3k 1.1k 1.0k 937 28 3.1k
Anne Barlier France 38 1.2k 0.9× 2.4k 1.9× 1.2k 1.2× 726 0.7× 469 0.5× 165 4.4k
Laura Papi Italy 25 892 0.7× 791 0.6× 610 0.6× 859 0.8× 766 0.8× 68 3.2k
Gérald Raverot France 43 1.5k 1.1× 4.3k 3.3× 1.9k 1.8× 478 0.5× 273 0.3× 181 5.6k
S.W.J. Lamberts Netherlands 28 1.7k 1.2× 957 0.7× 423 0.4× 962 0.9× 1.1k 1.2× 55 2.9k
Alexandru Saveanu France 33 1.3k 0.9× 1.9k 1.4× 494 0.5× 551 0.5× 391 0.4× 78 2.7k
Jacqueline Trouillas France 37 1.3k 0.9× 3.4k 2.6× 1.7k 1.6× 393 0.4× 206 0.2× 117 4.3k
Emily Gardner United Kingdom 14 794 0.6× 1.3k 1.0× 672 0.6× 360 0.4× 812 0.9× 30 2.8k
Trisha Dwight Australia 23 190 0.1× 606 0.5× 508 0.5× 173 0.2× 356 0.4× 42 1.6k
Paul Newey United Kingdom 18 1.0k 0.8× 440 0.3× 277 0.3× 642 0.6× 808 0.9× 39 1.8k
Outi Vierimaa Finland 16 326 0.2× 525 0.4× 369 0.3× 166 0.2× 265 0.3× 21 1.7k

Countries citing papers authored by Arnaud Murat

Since Specialization
Citations

This map shows the geographic impact of Arnaud Murat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Murat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Murat more than expected).

Fields of papers citing papers by Arnaud Murat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Murat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Murat. The network helps show where Arnaud Murat may publish in the future.

Co-authorship network of co-authors of Arnaud Murat

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Murat. A scholar is included among the top collaborators of Arnaud Murat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Murat. Arnaud Murat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bihan, H., Arnaud Murat, M. Fysekidis, et al.. (2013). The clinical spectrum of RET proto-oncogene mutations in codon 790. European Journal of Endocrinology. 169(3). 271–276. 10 indexed citations
2.
Bricaire, Léopoldine, Marie‐Françoise Odou, Catherine Cardot-Bauters, et al.. (2013). Frequent Large GermlineHRPT2Deletions in a French National Cohort of Patients With Primary Hyperparathyroidism. The Journal of Clinical Endocrinology & Metabolism. 98(2). E403–E408. 91 indexed citations
3.
Buffet, Alexandre, Sarra Smati, L Mansuy, et al.. (2013). Mosaicism inHIF2A-Related Polycythemia-Paraganglioma Syndrome. The Journal of Clinical Endocrinology & Metabolism. 99(2). E369–E373. 65 indexed citations
4.
Dubois, Séverine, Arnaud Murat, Nicole Berger, et al.. (2012). Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin‐stimulation test?. Clinical Endocrinology. 78(3). 358–364. 16 indexed citations
5.
Bièche, Ivan, Vinciane Rebours, Pascal Hammel, et al.. (2012). Molecular Profiling of Pancreatic Neuroendocrine Tumors in Sporadic and Von Hippel-Lindau Patients. Clinical Cancer Research. 18(10). 2838–2849. 47 indexed citations
6.
Barbe, Coralie, Arnaud Murat, B. Dupas, et al.. (2011). Magnetic resonance imaging versus endoscopic ultrasonography for the detection of pancreatic tumours in multiple endocrine neoplasia type 1. Digestive and Liver Disease. 44(3). 228–234. 46 indexed citations
7.
Goudet, Pierre, Arnaud Murat, Philippe Émy, et al.. (2009). Thymic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: A Comparative Study on 21 Cases Among a Series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines). World Journal of Surgery. 33(6). 1197–1207. 74 indexed citations
8.
Mirallié, Éric, B. Bridji, I. Resche, et al.. (2007). Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma. Surgery. 142(6). 952–958. 54 indexed citations
9.
Oudoux, A., Pierre‐Yves Salaün, Claire Bournaud, et al.. (2007). Sensitivity and Prognostic Value of Positron Emission Tomography with F-18-Fluorodeoxyglucose and Sensitivity of Immunoscintigraphy in Patients with Medullary Thyroid Carcinoma Treated with Anticarcinoembryonic Antigen-Targeted Radioimmunotherapy. The Journal of Clinical Endocrinology & Metabolism. 92(12). 4590–4597. 64 indexed citations
10.
Triponez, Frédéric, Pierre Goudet, P Cougard, et al.. (2006). Epidemiology Data on 108 MEN 1 Patients From the GTE With Isolated Nonfunctioning Tumors of the Pancreas. Annals of Surgery. 243(2). 265–272. 171 indexed citations
11.
Dodé, Catherine, Corinne Fouveaut, Geert Mortier, et al.. (2006). NovelFGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesis. Human Mutation. 28(1). 97–98. 63 indexed citations
12.
Dodé, Catherine, Luís Teixeira, Jacqueline Levilliers, et al.. (2006). Kallmann Syndrome: Mutations in the Genes Encoding Prokineticin-2 and Prokineticin Receptor-2. PLoS Genetics. 2(10). e175–e175. 315 indexed citations
13.
Murat, Arnaud, Brigitte Delemer, Alfred Penfornis, et al.. (2006). Prospective Endoscopic Ultrasonographic Evaluation of the Frequency of Nonfunctioning Pancreaticoduodenal Endocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1. The American Journal of Gastroenterology. 101(2). 266–273. 100 indexed citations
14.
Vergès, Bruno, Pierre Goudet, Arnaud Murat, et al.. (2002). Pituitary Disease in MEN Type 1 (MEN1): Data from the France-Belgium MEN1 Multicenter Study. The Journal of Clinical Endocrinology & Metabolism. 87(2). 457–465. 308 indexed citations
15.
Corvi, Raffaella, Fabienne Lesueur, Minerva Martínez‐Alfaro, et al.. (2001). RET rearrangements in familial papillary thyroid carcinomas. Cancer Letters. 170(2). 191–198. 13 indexed citations
16.
Niccoli‐Sire, Patricia, Arnaud Murat, V. Rohmer, et al.. (2001). Familial Medullary Thyroid Carcinoma with Noncysteine RET Mutations: Phenotype-Genotype Relationship in a Large Series of Patients. The Journal of Clinical Endocrinology & Metabolism. 86(8). 3746–3753. 112 indexed citations
17.
Murat, Arnaud, et al.. (2000). Le cancer médullaire de la thyroïde. 2(5). 430–437. 2 indexed citations
18.
Nord, Brita, Anton Platz, Soili Kytölä, et al.. (2000). Malignant melanoma in patients with multiple endocrine neoplasia type 1 and involvement of theMEN1 gene in sporadic melanoma. International Journal of Cancer. 87(4). 463–467. 38 indexed citations
19.
Cadiot, Guillaume, Albert Vuagnat, Arnaud Murat, et al.. (1999). Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Gastroenterology. 116(2). 286–293. 119 indexed citations
20.
Bardet, Stéphane, V. Rohmer, Arnaud Murat, et al.. (1996). 131I‐6β‐Iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clinical Endocrinology. 44(5). 587–596. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Barlier Breakdown of academic impact, for papers by Laura Papi Breakdown of academic impact, for papers by Gérald Raverot Breakdown of academic impact, for papers by S.W.J. Lamberts Breakdown of academic impact, for papers by Alexandru Saveanu Breakdown of academic impact, for papers by Jacqueline Trouillas Breakdown of academic impact, for papers by Emily Gardner Breakdown of academic impact, for papers by Trisha Dwight Breakdown of academic impact, for papers by Paul Newey Breakdown of academic impact, for papers by Outi Vierimaa
Rankless by CCL
2026